[(6S)-4-(3'-Cyanobiphenyl-4-yl)-2,3,9-trimethyl-6H-1-thia-5,7,8,9a-tetraazacyclopenta[e]azulen-6-yl]acetic acid methyl ester

ID: ALA3771129

PubChem CID: 15978962

Max Phase: Preclinical

Molecular Formula: C27H23N5O2S

Molecular Weight: 481.58

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)C[C@@H]1N=C(c2ccc(-c3cccc(C#N)c3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21

Standard InChI:  InChI=1S/C27H23N5O2S/c1-15-16(2)35-27-24(15)25(29-22(13-23(33)34-4)26-31-30-17(3)32(26)27)20-10-8-19(9-11-20)21-7-5-6-18(12-21)14-28/h5-12,22H,13H2,1-4H3/t22-/m0/s1

Standard InChI Key:  NCPYGYYERXQFSF-QFIPXVFZSA-N

Molfile:  

     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    4.0310   -1.8918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6839   -0.4316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1584   -2.7155    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4687   -2.3222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7198    2.8060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9871    1.9733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5888    0.5069    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1043    0.4164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -0.8690    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1586   -1.0862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2448    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0276    1.3940    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8690    2.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5431    1.8285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4121   -2.5707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1086   -3.2948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9957   -2.2448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1754   -2.4645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6528    4.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1093    2.3984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5380    6.7152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1481    6.1511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0584    4.6654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1266    3.7414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5149    4.3078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7214    5.7935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7446    8.2016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5626    9.1253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7715   10.6107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1623   11.1725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3442   10.2490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1354    8.7636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7462   -3.4897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4111   11.5348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3567   12.2736    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  5 14  1  0
  8 14  2  0
 15 16  1  0
 16 17  2  0
  9 17  1  0
 10 15  2  0
 17 18  1  0
  5 19  1  0
  6 20  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 21 26  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 27 32  2  0
 21 27  1  0
 13 24  1  0
 11  2  1  1
  4 33  1  0
 34 35  3  0
 29 34  1  0
M  END

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Daudi (625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD2 Tchem Bromodomain-containing protein 2 (1296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD3 Tchem Bromodomain-containing protein 3 (1086 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 481.58Molecular Weight (Monoisotopic): 481.1572AlogP: 5.25#Rotatable Bonds: 4
Polar Surface Area: 93.16Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.45CX LogP: 5.10CX LogD: 5.10
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.37Np Likeness Score: -1.05

References

1. Endo J, Hikawa H, Hamada M, Ishibuchi S, Fujie N, Sugiyama N, Tanaka M, Kobayashi H, Sugahara K, Oshita K, Iwata K, Ooike S, Murata M, Sumichika H, Chiba K, Adachi K..  (2016)  A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor.,  26  (5): [PMID:26869194] [10.1016/j.bmcl.2016.01.084]

Source